MRNA Moderna vaccine 94.5% effective in Phase 3 trial!

2020년 11월 16일

This was my previews post about Moderna:

The indicators are still bullish. The price of the stock grew 5X since the beginning of the year.

11/16/2020 Oppenheimer Boost Price Target ➝ $157.00
11/16/2020 Piper Sandler Boost Price Target ➝ $166.00

The traditional method of creating vaccines – introducing a weakened or dead virus, or a piece of one, to stimulate the body's immune system – takes over a decade on average, according to a 2013 study. One pandemic flu vaccine took over eight years while a hepatitis B vaccine was nearly 18 years in the making.
Moderna's vaccine went from gene sequencing to the first human injection in 63 days.
Moderna and BioNTech, for example, are also applying mRNA technology to experimental cancer medicines.
BioNTech's vaccine, for example, must be transported at minus 70 degrees Celsius, though Moderna said on Monday it can ship its candidate in normal refrigerators. (Reuters)

If you are interested to test some amazing BUY and SELL INDICATORS, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.